These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33647028)

  • 61. Maraviroc reactivates HIV with potency similar to that of other latency reversing drugs without inducing toxicity in CD8 T cells.
    López-Huertas MR; Jiménez-Tormo L; Madrid-Elena N; Gutiérrez C; Vivancos MJ; Luna L; Moreno S
    Biochem Pharmacol; 2020 Dec; 182():114231. PubMed ID: 32979351
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Specific Elimination of Latently HIV-1 Infected Cells Using HIV-1 Protease-Sensitive Toxin Nanocapsules.
    Wen J; Yan M; Liu Y; Li J; Xie Y; Lu Y; Kamata M; Chen IS
    PLoS One; 2016; 11(4):e0151572. PubMed ID: 27049645
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Selective cell death of latently HIV-infected CD4
    Zhang G; Luk BT; Wei X; Campbell GR; Fang RH; Zhang L; Spector SA
    Cell Death Dis; 2019 May; 10(6):419. PubMed ID: 31142734
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Selected P. falciparum specific immune responses are maintained in AIDS adults in Burkina Faso.
    Migot F; Ouedraogo JB; Diallo J; Zampan H; Dubois B; Scott-Finnigan T; Sanou PT; Deloron P
    Parasite Immunol; 1996 Jul; 18(7):333-9. PubMed ID: 9229386
    [TBL] [Abstract][Full Text] [Related]  

  • 65. HIV Controllers Have Low Inflammation Associated with a Strong HIV-Specific Immune Response in Blood.
    Hocini H; Bonnabau H; Lacabaratz C; Lefebvre C; Tisserand P; Foucat E; Lelièvre JD; Lambotte O; Saez-Cirion A; Versmisse P; Thiébaut R; Lévy Y
    J Virol; 2019 May; 93(10):. PubMed ID: 30814287
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.
    Huang SH; Ren Y; Thomas AS; Chan D; Mueller S; Ward AR; Patel S; Bollard CM; Cruz CR; Karandish S; Truong R; Macedo AB; Bosque A; Kovacs C; Benko E; Piechocka-Trocha A; Wong H; Jeng E; Nixon DF; Ho YC; Siliciano RF; Walker BD; Jones RB
    J Clin Invest; 2018 Feb; 128(2):876-889. PubMed ID: 29355843
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C-induced HIV latency reversal.
    Matsuda K; Kobayakawa T; Tsuchiya K; Hattori SI; Nomura W; Gatanaga H; Yoshimura K; Oka S; Endo Y; Tamamura H; Mitsuya H; Maeda K
    J Biol Chem; 2019 Jan; 294(1):116-129. PubMed ID: 30413535
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue.
    Biancotto A; Grivel JC; Gondois-Rey F; Bettendroffer L; Vigne R; Brown S; Margolis LB; Hirsch I
    J Virol; 2004 Oct; 78(19):10507-15. PubMed ID: 15367617
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.
    Capobianchi MR
    J Biol Regul Homeost Agents; 1996; 10(4):83-91. PubMed ID: 9604776
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Targeting Immune Checkpoint Molecules to Eliminate Latent HIV.
    Boyer Z; Palmer S
    Front Immunol; 2018; 9():2339. PubMed ID: 30459753
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Low Frequency of IL-17-Producing CD8
    Perdomo-Celis F; Feria MG; Taborda NA; Rugeles MT
    Front Immunol; 2018; 9():2502. PubMed ID: 30420859
    [TBL] [Abstract][Full Text] [Related]  

  • 72. BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency.
    Lu P; Shen Y; Yang H; Wang Y; Jiang Z; Yang X; Zhong Y; Pan H; Xu J; Lu H; Zhu H
    Sci Rep; 2017 Nov; 7(1):16646. PubMed ID: 29192216
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+ T Cells to HIV-1-Specific CD8+ T Cells.
    Walker-Sperling VE; Cohen VJ; Tarwater PM; Blankson JN
    J Virol; 2015 Sep; 89(18):9631-8. PubMed ID: 26178987
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Heme arginate potentiates latent HIV-1 reactivation while inhibiting the acute infection.
    Shankaran P; Vlkova L; Liskova J; Melkova Z
    Antiviral Res; 2011 Dec; 92(3):434-46. PubMed ID: 22001321
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Induction of HIF-1α by HIV-1 Infection in CD4
    Duette G; Pereyra Gerber P; Rubione J; Perez PS; Landay AL; Crowe SM; Liao Z; Witwer KW; Holgado MP; Salido J; Geffner J; Sued O; Palmer CS; Ostrowski M
    mBio; 2018 Sep; 9(5):. PubMed ID: 30206166
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Innate immune regulation in HIV latency models.
    Olson RM; Gornalusse G; Whitmore LS; Newhouse D; Tisoncik-Go J; Smith E; Ochsenbauer C; Hladik F; Gale M
    Retrovirology; 2022 Jul; 19(1):15. PubMed ID: 35804422
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells.
    Sung JA; Pickeral J; Liu L; Stanfield-Oakley SA; Lam CY; Garrido C; Pollara J; LaBranche C; Bonsignori M; Moody MA; Yang Y; Parks R; Archin N; Allard B; Kirchherr J; Kuruc JD; Gay CL; Cohen MS; Ochsenbauer C; Soderberg K; Liao HX; Montefiori D; Moore P; Johnson S; Koenig S; Haynes BF; Nordstrom JL; Margolis DM; Ferrari G
    J Clin Invest; 2015 Nov; 125(11):4077-90. PubMed ID: 26413868
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
    Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
    Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Heat Shock Protein 90 Facilitates Latent HIV Reactivation through Maintaining the Function of Positive Transcriptional Elongation Factor b (p-TEFb) under Proteasome Inhibition.
    Pan XY; Zhao W; Wang CY; Lin J; Zeng XY; Ren RX; Wang K; Xun TR; Shai Y; Liu SW
    J Biol Chem; 2016 Dec; 291(50):26177-26187. PubMed ID: 27799305
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection.
    Ezeonwumelu IJ; Garcia-Vidal E; Riveira-Muñoz E; Felip E; Gutiérrez-Chamorro L; Calba I; Massanella M; Sirera G; Clotet B; Ballana E; Badia R
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.